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Vitamin B12, folate, and homocysteine are implicated in pivotal neurodegenerative mechanisms and partake in elders’ mental decline.
Findings on the association between vitamin-related biochemistry and cognitive abilities suggest that the structural and functional
properties of the brain may represent an intermediate biomarker linking vitamin concentrations to cognition. Despite this, no
previous study directly investigated whether vitamin B12, folate, and homocysteine levels are suﬃcient to explain individual
neuropsychological proﬁles or, alternatively, whether the activity of brain regions modulated by these compounds better predicts
cognition in elders. Here, we measured the relationship between vitamin blood concentrations, scores at seventeen
neuropsychological tests, and brain activity of sixty-ﬁve elders spanning from normal to Mild Cognitive Impairment. We then
evaluated whether task-related brain responses represent an intermediate phenotype, providing a better prediction of subjects’
neuropsychological scores, as compared to the one obtained considering blood biochemistry only. We found that the hemodynamic
activity of the right dorsal anterior cingulate cortex was positively associated (p value < 0 05 cluster corrected) with vitamin B12
concentrations, suggesting that elders with higher B12 levels had a more pronounced recruitment of this salience network region.
Crucially, the activity of this area signiﬁcantly predicted subjects’ visual search and attention abilities (p value = 0 0023), whereas B12
levels per se failed to do so. Our results demonstrate that the relationship between blood biochemistry and elders’ cognitive abilities
is revealed when brain activity is included into the equation, thus highlighting the role of brain imaging as intermediate phenotype.
1. Introduction
Vitamin deﬁciencies due to dietary habits, drug interactions,
or genetic factors are quite common in the elderly and may
contribute to the worsening of cognitive decline [1, 2]. For
instance, vitamin B12 and folate are involved in the metabo-
lism of homocysteine (tHcy) [2, 3], and dysregulations in this
system are related to mental decay in elders, being also
involved in pivotal neurodegenerative mechanisms such as
oxidative stress and the triggering of apoptosis [4]. The
NHANES [5] and the Framingham Heart Study [6] demon-
strated that high folate levels or folic acid supplementation
might aggravate cognitive impairment associated with low
vitamin B12 serum levels. Furthermore, high tHcy concentra-
tions, together with folate and vitamin B12 deﬁciencies, are
related to cerebrovascular pathologies [7] and accelerate
brain ageing [8].
Despite the large amount of studies pointing to the
same direction, other observations cast doubt on the reli-
ability of the relationship between vitamin-related com-
pounds and cognitive status [9]. For instance, a large cohort
study on Alzheimer’s disease and Mild Cognitive Impair-
ment (MCI) patients did not ﬁnd any correlation between
cognitive functioning and vitamin B12, folate, or tHcy levels
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[10]. Similarly, in a double-blind randomized placebo-
controlled trial, Dangour et al. did not ﬁnd any positive eﬀect
of the supplementation of vitamin B12 on cognition [11].
Nonetheless, this trial included a limited number of subjects
(n = 99) with no sign of cognitive decline, and the treatment
was administered for a relatively brief period. Further-
more, a very recent investigation [12] showed no signiﬁcant
association between vitamin B12 levels and cognitive abilities
in healthy elders. Overall, as there is a considerable heteroge-
neity in the cognitive and biochemical characteristics of sam-
ples between reports, further investigations are required to
properly assess the relationship between blood biomarkers
and cognition in elders [13, 14].
To clarify whether and how vitamin-related compounds
aﬀect the cognitive status of elders, it may be necessary to
consider also information related to brain structure and func-
tion asmeasured by in vivo neuroimaging techniques. Indeed,
brain properties may represent a compelling biomarker able
to reveal how blood biochemistry contributes to cerebrovas-
cular health and aﬀects cognition. Accordingly, some studies
provided indirect evidence of the interconnection between
vitamin-related markers and behavior through the evalua-
tion of brain structural properties: global and hippocampal
atrophy are associated to high concentrations of tHcy [15,
16] and folate [15], while high B12 levels to decreased rates
of total brain volume loss through the years [8, 17]. Of note,
these structural alterations have been described not only in
demented individuals but also in healthy elders [18, 19],
indicating that blood biochemistry signiﬁcantly inﬂuences
brain morphology, regardless of the clinical diagnosis.
However, in sharp contrast with the abundance of
evidence linking biochemical markers to brain morpho-
logical alterations, less is known about the relationship with
brain functioning [20, 21]. Most importantly, to the best of
our knowledge, no previous study directly investigated
whether levels of vitamin-related compounds are suﬃcient
to explain cognition (Figure 1(a)) or, alternatively, brain
hemodynamic properties act as an intermediate phenotype
providing a signiﬁcant prediction of subjects’ cognitive pro-
ﬁles (Figure 1(b)). Thus, to ﬁll this gap in the literature, we
measured the correlation between vitamin B12, folate, and
tHcy blood levels and brain activity during a visuospatial
attention task [22] in a group of sixty-ﬁve nondemented
elders, with normal cognition or MCI diagnosis. We then
ascertained whether brain regions signiﬁcantly modulated
by concentrations of vitamin-related compounds predicted
subjects’ cognitive proﬁles, as measured through a compre-
hensive neuropsychological assessment.
2. Methods
2.1. Subjects. From the initial cohort of a longitudinal project
[22] (the Train the Brain study; ClinicalTrials.gov Identiﬁer:
NCT01725178), we selected subjects who completed the
neuropsychological, biochemical, and MRI assessment
(see Supplementary Figure 1 for a recruitment ﬂowchart).
Seventy-four elders were then included in the current study
(35 males; mean age ± standard deviation: 74 ± 5 years; edu-
cation: 10 ± 5 years; Mini Mental State Examination (MMSE)
score: 26 1 ± 2 1). Neuropsychological and neurological
evaluations assessed subjects’ cognitive and physical state
and excluded a diagnosis of moderate or severe dementia
(Clinical Dementia Rating > 1) and depression (Geriatric
Depression Scale≥ 9), as well as other psychiatric, neuro-
logical, or medical conditions.
In accordance with the European Consortium on
Alzheimer’s Disease Working Group on MCI criteria [23],
participants’ cognitive state ranged from normal (n = 18) to
MCI (n = 56).
Subjects gave their written informed consent to take part
in the study and had the right to withdraw at any time. Pro-
tocol and procedures were approved by the local Ethical
Committee for Clinical Experimentation and the study was
conducted in accordance with the Declaration of Helsinki.
Prior to the analyses, we discarded nine subjects due
to the following reasons: (i) their B12, folate, and tHcy
values were higher or lower than 3 standard deviations
from the group average (recursive outlier detection proce-
dure; n = 5) and (ii) they had excessive head movement
during fMRI acquisition (n = 4; see MRI Data Analysis).
Thus, the data of 65 elders have been used to test the relation-
ship between blood biochemistry, brain activity, and cogni-
tive proﬁles: 30 males; mean age ± standard deviation: 74 ±
5 years; education: 10 ± 5 years; and MMSE score: 25 9 ±
2 0. There were 15 healthy elders (HE) and 27 elders with
amnestic single-domain MCI, 16 with amnestic multiple
domain MCI, ﬁve with nonamnestic single-domain MCI,
and two with nonamnestic multiple domain MCI.
2.2. Data Acquisition
2.2.1. Neuropsychological Assessment. To characterize the
cognitive state of our sample, expert neuropsychologists
administered a comprehensive battery of 18 tests, investigat-
ing multiple cognitive domains. A detailed description is pro-
vided in Supplementary Materials. Sample characteristics
and test results are reported in Supplementary Table 1.
2.2.2. Clinical Biochemistry Evaluation. Subjects underwent a
fasting blood sampling procedure within one week prior to
MRI acquisition. Blood analyses were performed by the
Clinical Biochemistry Laboratory of the Azienda Ospedaliera
Universitaria Pisana (Pisa, Italy) which also included routine
blood tests. B12 and folate serum levels were evaluated by an
electrochemiluminescence immunoassay (ECLIA) (Roche
Diagnostics, Basilea, Switzerland) on a cobas immunoanaly-
zer (Roche Diagnostics, Basilea, Switzerland), whereas tHcy
was evaluated in plasma by the automated latex enhanced
immunoassay HemosIL (Werfen, Barcelona, Spain) on an
ACL TOP 500 instrument (Werfen, Barcelona, Spain).
2.2.3. Magnetic Resonance Imaging. MRI data were
acquired on a GE HDxt 1.5T Signa (General Electric
Healthcare) system, equipped with an 8-channel phased-
array head coil. For each subject, an exhaustive MR session
was performed, including a clinical protocol (i.e., T2w FSE,
FLAIR, and T2∗GRE) reviewed by an expert neuroradiol-
ogist that ensured the absence of pathological conditions.
A T1-weighted 3D fast spoiled gradient recall sequence
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(TR/TE = 12 650/5 300ms, prep time = 700ms, NEX = 1,
FOV = 256mm, acquisitionmatrix = 256 × 256, isotropic
voxel = 1 × 1 × 1mm, and approximately 10 minutes of
scan time) provided high-resolution structural images of
the brain, whereas a gradient recall echo-echo planar imaging
sequence (TR/TE = 2500/50ms; FA = 90°; FOV = 192mm;
acquisitionmatrix = 64 × 64; isotropic voxel = 3 × 3 × 3mm;
33 interleaved axial slices; partial brain coverage: ~10 cm;
three runs; 60 + 4 dummy volumes each; and 8-minute over-
all scan time) measured hemodynamic responses elicited by a
visuospatial attention task [22]. During the MR session, par-
ticipants wore MR-compatible goggles (VisuaStim, Reso-
nance Technology Inc.; 30 × 22 5 deg visual ﬁeld size)
that allowed the projection of visual stimuli. Two buttons
(held in the left and right hands) were also provided and used
to track the subject’ responses during task execution.
2.2.4. Stimuli and Experimental Paradigm. The experimental
apparatus (i.e., goggles and response pads) was connected to
a workstation running MATLAB Release 2010b 64 bit (The
MathWorks Inc., Natick, MA, USA). The visuospatial atten-
tion task was implemented in the Psychtoolbox v3.0.947 [24]
and administered during the fMRI acquisition. In brief, sub-
jects were asked to covertly track four stimuli (i.e., two red
and two blue dots) while gazing on a central ﬁxation point.
The four dots were moving randomly at a constant speed of
6 deg/s. Two near-peripheral (i.e., 7.5 deg of eccentricity) col-
ored targets were located to the right (i.e., red target) and to
the left (i.e., blue target) of the ﬁxation point. Participants
had to press the correct response button whenever one
stimulus hit the target of the same color and their perfor-
mance was recorded in real-time (see Supplementary
Figure 2). Overall, subjects had to accomplish nine
repetitions of the task across three runs. Hence, each run
comprised three blocks of tasks, lasting 30 seconds each,
alternated with four resting intervals (15 seconds each).
During rest periods, only the two static targets were
presented and subjects were instructed to gaze the central
ﬁxation point, without focusing on speciﬁc thoughts. To
familiarize subjects with task procedure, a brief training
session was provided outside the scanner room, which
ensured all participants to achieve at least 66% accuracy.
Biochemical, neuropsychological, and MRI data are available
upon request.
2.3. Data Analysis
2.3.1. Neuropsychological Assessment. Scores at neuropsy-
chological tests were adjusted for age and education and
transformed into Z-scores (excluding the MMSE). Pearson’s
coeﬃcient estimated the correlation among them, and
the level of signiﬁcance was corrected for multiple com-
parisons through the False Discovery Rate procedure [25]
(p valueFDR < 0 05). Principal component analysis was
implemented in MATLAB (release 2010b 64 bit) and led to
17 linearly uncorrelated dimensions (i.e., cognitive proﬁles),
each representing an aggregate measure of subjects’ perfor-
mance at several tests. This approach was employed to solve
the high collinearity in the neuropsychological evaluation,
since each test engages multiple cognitive systems [26].
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Figure 1: The two alternative hypotheses for the relationship between blood biochemistry, brain activity, and cognitive proﬁles. (a) Scheme
depicting the potential role of B12, folate, tHcy, and their interactions as direct predictors of distinct cognitive proﬁles. These proﬁles are
represented by principal components (PC) derived from subjects’ scores at seventeen neuropsychological tests. Age, years of education,
Mini Mental State Examination scores and fMRI task accuracy are included in the model as nuisance variables. (b) Alternatively, brain
hemodynamic activity can act as an intermediate phenotype in linking blood biochemistry to subjects’ cognitive proﬁles. First, brain
regions modulated by B12, folate, tHcy, and their interactions are identiﬁed and hemodynamic activity is subsequently used as a predictor
of cognitive proﬁles. The same nuisance variables are included in the model at both steps of analysis. tHcy: homocysteine; Fol: folate;
MMSE: Mini Mental State Examination.
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Given that PC scores are, by deﬁnition, uncorrelated to each
other, they were used to assess the relationship between
blood biochemistry, task-evoked brain activity, and cogni-
tive proﬁles using independent tests.
2.3.2. Clinical Biochemistry Evaluation. In our ﬁnal sam-
ple (n = 65), the average level (±standard deviation) of vita-
min B12 was 400 6 ± 145 7 pg/mL (range: 124-779 pg/mL),
whereas for folate and tHcy the average values were 6 7 ±
2 2 ng/mL (range: 3.2-12.0 ng/mL) and 10 2 ± 3 4 μmol/L
(range: 4.0-18.8μmol/L), respectively. B12, folate, and tHcy
values were transformed into Z-scores and interaction
terms were estimated: tHcy∗folate, tHcy∗B12, and folate∗
B12. Negative scores for the interaction terms reﬂected a
valuable imbalance between blood levels of vitamin-
related compounds, whereas positive values indicated that
both biochemical markers were either above or below aver-
age. As previous evidence revealed the existence of a rela-
tionship between these compounds and age [18], MMSE
scores [27], and clinical diagnosis [28], we performed a
comprehensive set of supporting analyses, detailed in
Supplementary Materials.
Moreover, we evaluated whether vitamin-related com-
pounds would signiﬁcantly predict subjects’ cognition, as
measured by PCs (Figure 1(a)). Seventeen independent gen-
eral linear models (GLMs) veriﬁed this relationship: blood
marker concentrations and their interactions were treated
as variables of interest, while age, years of education, MMSE
scores, and fMRI task accuracy were treated as nuisance var-
iables. The assessment of statistical signiﬁcance was per-
formed using a nonparametric permutation approach, as
detailed below (see MRI Data Analysis). Results were cor-
rected for multiple comparisons using the Bonferroni
method (Bonferroni corrected p value < 0 05; pcrit = 0 0029).
2.3.3. fMRI Task Performance. In the whole sample, ranging
from healthy to mild cognitive impaired subjects, we tested
the relationship between fMRI task performance and age,
MMSE scores, clinical diagnosis, and blood biochemistry
(see Supplementary Materials). Furthermore, we used 17
independent GLMs to measure the relationship between
fMRI task performance and PC scores, while adjusting the
results for age, years of education, and MMSE (Bonferroni
corrected p value < 0 05; pcrit = 0 0029).
2.3.4. MRI Data Analysis.MRI data were extensively prepro-
cessed to rule out potential confounds related to physiologi-
cal, as well as acquisition-related artifacts, and analyzed
using ANTs [29], AFNI v.17.2.00 [30], and FSL v.5.0.9 [31].
For a comprehensive description of single-subject processing
steps, please refer to Supplementary Materials. Group-level
correlation between brain activity and blood biochemistry
was evaluated through a mixed-eﬀect model (3dMEMA),
which considered within- and between-subject variability.
B12, folate, tHcy, and the interaction terms represented the
regressors of interest for the group-level analysis, while Z
-transformed age, education, MMSE, and task accuracy at
the visuospatial attention task were included as confounds.
Signiﬁcance of the group-level correlation was corrected for
multiple comparisons through AFNI’s cluster-based method
(3dClustSim; two-tailed p value < 0 005 for the cluster-
forming threshold and p value < 0 05 for cluster signiﬁcance),
considering the average spatial autocorrelation of the data
across subjects.
Lastly, we assessed whether cerebrovascular activity acts
as an intermediate phenotype, indirectly linking blood bio-
chemistry to cognition in nondemented elders. To this
purpose, the activity of brain regions showing signiﬁcant
group-level correlation with vitamin-related compounds
was used as a predictor of cognitive proﬁles. Thus, for
each of the identiﬁed regions, we performed 17 indepen-
dent GLMs using subjects’ hemodynamic activity as the
explanatory variable. Age, years of education, and MMSE
scores as well as fMRI task accuracy were included as nui-
sance regressors and each PC score was included as the
response variable. To robustly estimate the statistical signiﬁ-
cance of each test, we adopted a permutation approach in
which both dependent and independent matrices of the
GLMs were rearranged (100,000 permutations) by shuﬄing
values within each column (i.e., permuting subject ID), sepa-
rately. This procedure generated a null distribution of regres-
sion coeﬃcients, against which the actual association was
tested. The resulting p values were corrected for multiple
comparisons through the Bonferroni method (Bonferroni
corrected p value < 0 05; pcrit = 0 0029).
3. Results
3.1. Neuropsychological Assessment. As depicted in
Figure 2(a) and detailed in Supplementary Materials, we
observed several signiﬁcant correlations among scores at dif-
ferent neuropsychological tests. Principal components (i.e.,
cognitive proﬁles) were computed and interpreted according
to the loadings of the seventeen cognitive tests (Figure 2(b)).
3.2. Clinical Biochemistry Evaluation. Results for the rela-
tionship between blood biochemistry and subjects’ cognitive
performance as measured by the PCs are shown in Table 1
and Supplementary Figures 4(A) and 5(A). We found a
negative association between working memory abilities
versus lexical access speed (Figure 2(b); 12th PC) and both
folate and B12∗folate levels, as well as a positive association
between tHcy∗folate interaction and attention performance
versus verbal ﬂuency scores (Figure 2(b); 15th PC). Besides
these, neither additional biochemical markers, nor other
interactions, signiﬁcantly predicted any cognitive proﬁle
(Supplementary Table 2).
3.3. fMRI Task Performance. Average task performance ±
standard deviation across individuals was 80 3% ± 8%.
None of the linear associations between fMRI task accu-
racy and PCs reached statistical signiﬁcance (see Supple-
mentary Table 7). Results from other supporting analyses
are detailed in Supplementary Materials.
3.4. MRI Data. Overall, during the execution of the visuo-
spatial attention task, participants recruited a widespread
bilateral network (Figure 3(a)).
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Interestingly, results for the relationship between vitamin-
related compounds and brain activity highlighted a signiﬁcant
ROI within the task-positive network: hemodynamic activity
of the right dorsal anterior cingulate cortex (dACC; center
of gravity: x = +5, y = +36, z = +28; peak of association: x =
+6, y = +34, z = +28) was positively associated with B12
serum concentrations (β = 0 551; Figures 3(b) and 4(b)).
The average group-level signal of this area was positive dur-
ing task blocks (+1.36%), suggesting that participants with
higher B12 levels had a more pronounced recruitment of this
salience network region [32].
Most importantly, dACC activity signiﬁcantly pre-
dicted (β = 0 388, raw p value = 0 0023; Bonferroni corrected
p value = 0 039; Figures 5(a) and 5(b); Figure 4(b); Table 2;
Table 1: Predictive power of biochemical markers on cognitive proﬁles.
PC1 PC7 PC12 PC15
β p β p β p β p
tHcy .011 .9322 -.068 .6180 -.138 .3098 -.076 .5790
Folate -.080 .5563 .021 .8841 -.409 .0021 .154 .2616
B12 .222 .1034 .171 .2071 -.147 .2746 .007 .9567
B12∗folate .189 .1629 -.117 .3926 -.480 .0002 .012 .9254
B12∗tHcy .037 .7844 .066 .6272 -.139 .3076 -.081 .5522
tHcy∗folate .149 .2689 .007 .9604 -.253 .0618 .428 .0011
Age -.154 .2596 .431 .0009 -.175 .2004 .038 .7802
Education .101 .4625 .346 .0097 .233 .0840 .031 .8185
MMSE scores .553 .0000 -.042 .7674 -.042 .7621 .325 .0164
fMRI task accuracy .037 .7912 -.029 .8342 .126 .3566 -.060 .6629
Model: PCj=α+β tHcy+β folate+β B12+β B12∗folate+β B12∗tHcy+β tHcy∗folate+β age+β education+β MMSE+β fMRI task accuracy; italicized values
represent p < 0 05 uncorrected; bold values represent p < 0 05 Bonferroni corrected; tHcy=homocysteine; MMSE=Mini Mental State Examination;
PC=principal component.
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Figure 2: Neuropsychological assessment results. (a) Correlations among all the seventeen neuropsychological tests as estimated by Pearson’s
coeﬃcient. Marked cells refer to signiﬁcant correlations corrected for multiple comparisons through the False Discovery Rate procedure. (b)
Matrix describing the results of the principal component analysis and showing seventeen uncorrelated cognitive proﬁles, tests loadings, and
the proportion of variance explained by each component. As a matter of fact, the ﬁrst principal component (explained variance: 29.1%)
highlighted subjects’ global cognitive performance, since all the neuropsychological tests jointly contributed to it and given its high
correlation with MMSE scores (r = 0 522, p value = 8 2 ∗ 10−6). AVLT: Auditory Verbal Learning Test; Imm: immediate recall; Delay:
delayed recall.
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Supplementary Table 3) the cognitive proﬁle related to
subjects’ spatial attention and search abilities versus verbal
memory performance (11th PC: Trail Making Test A
loading = 0 512; Babcock delayed story recall loading =
−0 411; Figure 2(b)). In addition, by considering B12 levels
only it was not possible to explain subjects’ performances
for any of the cognitive proﬁles (see Supplementary Table 2
and Figure 4(a)). Of note, this result was not aﬀected by
the exclusion of healthy elders from the analysis: when
considering MCI patients only (n = 50), the association
between dACC activity and the 11th PC was still signiﬁcant
(β = 0 433, raw p value = 0 0027). Taken together, these
results highlighted the role of task-positive brain activity as
an intermediate phenotype, linking blood biochemistry to
cognition throughout the normal-to-pathology continuum.
Moreover, other regions of the task-negative network,
modulated by vitamin-related compounds (Supplementary
Figure 3), did not add a relevant contribution to the
prediction of cognitive proﬁles, which can be solved by
simply considering blood biochemistry (see Supplementary
Materials).
4. Discussion
In the present study, we used magnetic resonance imaging,
blood biochemistry, and neuropsychological assessment to
investigate whether functional characteristics of the brain,
mediated by B12, folate, and tHcy concentrations, represent
an intermediate phenotype able to signiﬁcantly predict
single-subject cognitive proﬁles. Our results demonstrated
that, in sixty-ﬁve nondemented elders performing a visuo-
spatial attention task, B12 levels were positively associated
to hemodynamic responses in the right dACC. Crucially,
the activity of this brain region, but not B12 levels per se, pre-
dicted participants’ spatial attention and visual search abili-
ties as measured by an independent neuropsychological
evaluation (Figure 4). This ﬁnding unveiled how B12 contrib-
utes to cerebrovascular health, indirectly aﬀecting cognition
and mental eﬃciency in healthy elders and in prodromal
stages of dementia.
Some authors suggested that in old age B12 serum
levels together with folate concentrations have a fundamen-
tal role in genomic and nongenomic methylation, and their
deﬁciencies trigger homocysteine-mediated neurotoxicity
[33]. In addition, the eﬀects of this vitamin on cognition have
been demonstrated throughout the normal-to-pathology
continuum [1, 6].
This relationship has been further corroborated by
reports linking B12 concentrations to brain structural proper-
ties, mainly focusing on global parenchymal atrophy and
white-matter lesions. Vogiatzoglou et al. showed that healthy
elders with lower B12 levels had higher global atrophy scores
and increased rate of brain volume loss [34]. Studies have
reported a protective eﬀect of high blood concentrations [8]
and dietary intake [19] of B12 on the brain atrophy rate
in healthy elders, as well as in MCI patients [2]. Similarly,
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Figure 3: Brain activity results. (a) fMRI task-evoked activity across subjects entails medial and lateral occipital regions (i.e., primary and
motion-sensitive visual cortex), the dorsal parietal attention network (intraparietal sulcus and superior parietal lobule), frontal areas
involved in motor control and focusing (ventral and dorsal premotor, as well as the supplementary motor), and nodes of the salience
network (e.g., anterior insula). Regions enclosed in black survived the Bonferroni correction for multiple comparisons (p value < 0 05). (b)
Results for the relationship between biochemical markers and task-evoked brain activity. Hemodynamic activity of the right dorsal
anterior cingulate cortex (dACC), located within the task-positive network, was found to be signiﬁcantly associated with B12 serum
concentrations (two-tailed p value < 0 005 for the cluster-forming threshold and α < 0 05 for cluster signiﬁcance).
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Figure 5: Predictive power of brain activity on cognitive proﬁle. (a) Scatter plot depicting the relationship between hemodynamic activity of
the right dorsal anterior cingulate cortex (dACC) and the cognitive proﬁle expressed by the 11th component (PC), related to subjects’ spatial
attention and search abilities (i.e., scores at the Trail Making Test A versus delayed recall of the Babcock story). (b) Null distribution of
regression coeﬃcients against which the relationship between right dACC activity and cognitive proﬁle expressed by the 11th component
was tested. The blue dot indicates the actual relationship between the right dACC and the 11th PC; dotted lines represent p value < 0 05
uncorrected threshold, while dashed lines represent p value < 0 05 Bonferroni corrected.
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Figure 4: Resulting model for the relationship between blood biochemistry, right dACC activity, and cognitive proﬁles. (a) Scheme depicting
the role of B12, folate, tHcy, and their interactions, as direct predictors of the cognitive proﬁle expressed by the 11th component (PC). No
signiﬁcant associations were found between biochemical markers and cognitive status. Loadings of each neuropsychological test for the
11th component are color coded: the more intense the red is, the more positive is the loading of a test; vice versa, the more intense the
blue is, the more negative the loading. Age, years of education, Mini Mental State Examination scores, and fMRI task accuracy are
included in the model as nuisance variables. (b) Activity of the right dACC signiﬁcantly acts as an intermediate phenotype in linking B12
serum levels to subjects’ spatial attention and search abilities. Indeed, the right dACC hemodynamic activity correlated with B12 serum
levels (β = 0 55) and predicted PC11 (β = 0 39). Please note that B12 levels per se were not able to predict the same cognitive proﬁle. In
both panels, arrow thickness represents the strength of the association between variables. Signiﬁcant relationships are marked with colored
arrows (positive relationships red, negative blue). The same nuisance variables are included in the model at both steps of analysis. RPM:
Raven’s Progressive Matrices; AVLT: Rey Auditory Verbal Learning Test; BSRT: Babcock Story Recall Test; DS: Forward Digit Span;
AMT: Attentional Matrices Test; TMT: Trail Making Test; ROCF: Rey-Osterrieth Complex Figure; CBTT: Corsi Block-Tapping Test;
FDT: Freehand Drawing Test; PCT: Planned Copy Test; PFT: Phonemic Fluency Test; SFT: Semantic Fluency Test; Imm: immediate
recall; Del: delayed recall; tHcy: homocysteine; Fol: folate; MMSE: Mini Mental State Examination.
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the severity of white-matter lesions is negatively related to
vitamin concentrations [35], as testiﬁed also by a recent
diﬀusion tensor imaging study [36].
Despite the abundance of structural MRI ﬁndings, less is
known about how B12 aﬀects brain functioning. To our knowl-
edge, only two studies investigated this issue: one showed that
regional homogeneity of resting state hemodynamic activity is
reduced in patients suﬀering B12 deﬁciencies, especially within
the default mode and the cinguloopercular and frontoparietal
networks [20]. The other one demonstrates that the same
patients exhibited reduced occipitoparietal and increased
frontal cerebral blood ﬂow values [21].
In the current report, we found that B12 serum concentra-
tions are positively associated to the right dACC hemody-
namic activity during a visuospatial attention task that
engages attention-, action-planning-, and motor-control-
related brain regions [22]. The dACC has rich connectivity
with the anterior insular (AI) cortex through the uncinate fas-
ciculus and many eﬀerent motor projections [37]. Interest-
ingly, together with AI, dACC is considered a crucial node
of the salience network, which is part of the task-positive net-
work [38] and sustains the detection of cognitively relevant
events [32]. Indeed, the Neurosynth (http://old.neurosynth
.org; [39]) association terms related to the peak coordinates
of the right dACC were “salience” (posterior probabil-
ity=0.74; z − score = 5 17) and “salience network” (posterior
probability=0.82; z − score = 5 05). The salience network is
thought to activate the executive network and to deactivate
the default mode network during the execution of tasks ori-
ented toward the environment [40–42]. Particularly, within
the salience network, dACC is devoted to response selection
[43] and conﬂict monitoring [44], two crucial activities for
the proper execution of our visuospatial task. A previous
study unveiled the relationship between dACC activity during
a response inhibition task and clinical diagnosis: compared to
Alzheimer’s disease patients,MCI demonstrated a compensa-
tory mechanism, leading to an increase in the hemodynamic
activity of this region [45]. Evidence from resting state
connectivity further highlighted the association between
salience network integrity and overall cognitive state [46].
In our study, we aimed to overcome the dichotomy
imposed by the clinical evidence and to ascertain whether
the task-related brain activity mediates the eﬀects of blood
biochemistry on individual neuropsychological proﬁles,
regardless of the diagnosis. It is worth mentioning that it
was not possible to predict subjects’ performance at neuro-
psychological tests by simply considering B12 serum concen-
trations (Figure 4(a)). However, by including brain activity in
the equation, we were able to signiﬁcantly estimate elders’
cognition: individuals with higher spatial attention and visual
search abilities (and lower verbal memory performances)
have a more substantial recruitment of dACC, whose activity
is positively modulated by B12 (Figure 4(b)). Interestingly, in
our data only the right dACC acted as an intermediate phe-
notype connecting B12 concentrations to the single-subject
cognitive state in healthy elders and in prodromal stages of
dementia. The right lateralization of this ﬁnding is not sur-
prising, as our task requires the engagement of visuospatial
abilities, and the processing of the spatial characteristics of
stimuli mainly relies on right hemisphere computations
[47]. This general observation is supported by lesion studies
and neuropsychological literature (see [48]), as well as by
in vivo neuroimaging investigations [49, 50]. Other studies
also demonstrated that this right lateralization holds for error
processing and conﬂict monitoring [51], as well as for visuo-
spatial processing [52] in dACC.
In addition, the inclusion of B12 as a confound in the
correlation analysis between the right dACC and the cog-
nitive proﬁle did not alter the signiﬁcance of their association
(β = 0 392, raw p value = 0 0022; Bonferroni corrected p
value = 0 037; Supplementary Table 5). This evidence clearly
indicates that distinct mechanisms related to serum B12
concentrations and visual search abilities jointly inﬂuence
dACC activity.
From a more general perspective, our results suggest that
only task-positive brain activity signiﬁcantly contributes to
solve the indirect relationship between blood biochemistry
and cognitive proﬁles, while the hemodynamic activity of
task-negative regions may not (see also Supplementary
Materials). Indeed, further studies including diﬀerent fMRI
paradigms (e.g., verbal naming and lexical decision) and
blood tests are required to better characterize whether only
the task-positive activity represents a proper brain marker,
linking biochemistry to cognitive proﬁles. We trust that
the adoption of other tasks (e.g., memory encoding) may
unveil relationships between clinical biochemistry, the
activity of speciﬁc brain regions (e.g., the hippocampus),
and subjects’ neuropsychological proﬁles (e.g., scores
at verbal memory tests versus performance at executive
functions tests).
Furthermore, it is relevant to note that subjects’ accuracy
at the visuospatial attention task recorded during fMRI
acquisition did not correlate with any of the cognitive pro-
ﬁles, or with any of the vitamin-related compounds except
for the B12∗tHcy interaction (β = 0 335, p value = 0 006; Sup-
plementary Table 7). Hence, the role of dACC as a B12
intermediate phenotype does not simply depend on a direct
association between subjects’ abilities at two diﬀerent tasks
(i.e., the one designed for the fMRI experiment and Trail
Making Test A) investigating the same cognitive domain
(i.e., visuospatial abilities).
Table 2: Predictive power of right dACC activity on cognitive
proﬁles.
PC1 PC7 PC11
β p β p β p
Right dACC .188 .1467 .210 .1049 .388 .0023
Age -.233 .0713 .446 .0003 .142 .2737
Education .104 .4276 .356 .0047 -.023 .8642
MMSE scores .565 .0000 -.055 .6728 .113 .3870
fMRI task accuracy -.001 .9918 -.045 .7291 .007 .9592
Model: PCj=α+β right dACC+β age+β education+β MMSE+β fMRI task
accuracy; underlined values represent p < 0 05 uncorrected; bold values
represent p < 0 05 Bonferroni corrected; dACC=dorsal anterior cingulate
cortex; MMSE=Mini Mental State Examination; PC=principal component.
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In summary, our study is the ﬁrst to prove that model-
ling brain activity as an intermediate factor between
biochemical markers and cognition unveils their indirect
relationship. This evidence suggests that the endophenoty-
pic approach, successfully adopted to explore associations
between genes, brain, and complex behaviors [53], can
be extended to biochemical factors, a possibility hitherto
neglected.
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